The experimental design in examination of acute myocardial infarctions should be valid in terms of flow, perfusion and re-flow after intervention. The contrast agents concentration in experimental studies can be measured by microdialysis. We have assessed the usefulness of different extracellular a
β¦ LIBER β¦
Newer fibrinolytic agents in patients with acute myocardial infarction
β Scribed by Pier Mannuccio Mannucci; Elena Faioni
- Publisher
- Springer
- Year
- 1986
- Tongue
- English
- Weight
- 539 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0940-5437
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Contrast agents in acute myocardial infa
β
Hemmingsson, A
π
Article
π
2001
π
Springer
π
English
β 51 KB
Disopyramide pharmacokinetics in patient
β
P. J. PentikΓ€inen; H. Huikuri; A. J. Jounela; G. Wilen
π
Article
π
1985
π
Springer
π
English
β 647 KB
Antioxidant status in patients with acut
β
Neela Patil; Vishwas Chavan; N. D. Karnik
π
Article
π
2007
π
Association of Clinical Biochemistry of India
π
English
β 80 KB
Fibrinolytic measurements in Type 2 diab
β
Mansfield, M.W.; Catto, A.J.; Carter, A.M.; Grant, P.J.
π
Article
π
1998
π
John Wiley and Sons
π
English
β 92 KB
π 1 views
The aim of this study was to investigate disturbances in fibrinolytic components in Type 2 diabetes patients with acute ischaemic stroke. Levels of plasminogen activator inhibitor-1 (PAI-1) activity and tissue PA (t-PA) antigen were measured in Type 2 diabetes subjects with (n=40) and without (n=80)
Serum lipid profile in patients with acu
β
P. K. Nigam; V. S. Narain; M. Hasan
π
Article
π
2004
π
Association of Clinical Biochemistry of India
π
English
β 281 KB
Primary stenting in nonselected patients
β
David Antoniucci; Renato Valenti; Guia Moschi; Maurizio Trapani; Leonardo Bologn
π
Article
π
2000
π
John Wiley and Sons
π
English
β 61 KB
π 2 views